China Pharmaceutical Market Outlook – Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 China Pharmaceutical Market Outlook – Introduction 8
3 China Pharmaceutical Market Outlook – Macroeconomic Analysis 9
3.1 General Economics 9
3.1.1 Gross Domestic Product 9
3.1.2 Inflation 11
3.1.3 Exchange Rate 12
3.1.4 Trade Balance 13
3.1.5 Foreign Direct Investment 17
3.2 Demographic 18
3.2.1 Population Size 18
3.2.2 Population Distribution 20
3.3 Health and Healthcare 22
3.3.1 Healthcare Expenditure 22
3.3.2 Public and Private Expenditure 25
3.3.3 Healthcare Facilities 27
3.3.4 Immunization 29
3.3.5 Smoking and Alcohol Use Prevalence 30
3.3.6 Obesity 32
3.3.7 Life Expectancy 33
3.3.8 Leading Causes of Death 34
4 China Pharmaceutical Market Outlook – Market Segments 35
4.1 Branded and Generic Drugs 35
4.2 Over-the-Counter and Prescription Drugs 39
4.3 Biopharmaceuticals 42
5 China Pharmaceutical Market Outlook – Industry Characteristics 44
5.1 Pricing Policy 44
5.2 Regulatory Landscape 45
5.2.1 Drug Manufacturing Regulations 46
5.2.2 New Drug Approval 46
5.2.3 Intellectual Property Protection 47
5.2.4 Advertising 47
5.3 Healthcare Overview 48
5.3.1 Healthcare Reform 48
5.3.2 Insurance and Reimbursement 49
5.4 Pharmaceutical Supply Chain 50
6 China Pharmaceutical Market Outlook – Competitive Landscape 51
6.1 Domestic Companies in China 51
6.1.1 Sinopharm 51
6.1.2 Shanghai Pharmaceutical 52
6.1.3 Jointown Pharmaceutical 52
6.1.4 Nanjing Pharmaceutical 53
6.1.5 Harbin Pharmaceutical 53
6.2 Macroscopic Domestic Deals Overview 54
6.3 Foreign Companies in China 56
7 China Pharmaceutical Market Outlook – Market Drivers and Barriers 57
7.1 Drivers 57
7.1.1 Increasing Overweight and Obese Population 57
7.1.2 High Smoking Prevalence 57
7.1.3 Aging Population 58
7.1.4 Government Financial Support 58
7.1.5 Healthcare Reforms 58
7.1.6 Increasing Urbanization 59
7.2 Barriers 59
7.2.1 Poor Drug Quality 59
7.2.2 Competition from Neighboring Countries 59
7.2.3 Popularity of TCM 59
7.2.4 Increasing Labor Costs 60
7.2.5 Poor Intellectual Property Protection 60
8 China Pharmaceutical Market Outlook – Appendix 61
8.1 Market Definitions 61
8.2 Abbreviations 61
8.3 Bibliography 62
8.4 Research Methodology 64
8.4.1 Coverage 64
8.4.2 Secondary Research 64
8.4.3 Primary Research 64
8.4.4 Expert Panel Validation 65
8.5 Contact Us 65
8.6 Disclaimer 65